BO 1341
| Code | Size | Price |
|---|
| TAR-T30555-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
BO 1341 is a semisynthetic cephalosporin.
CAS:
119068-46-1
Formula:
C26H24N6O9S2
Molecular Weight:
628.63
Purity:
0.98
SMILES:
[H][C@]12SCC(C[n+]3ccc4cc(O)c(O)cc4c3)=C(N1C(=O)[C@H]2NC(=O)C(=NOC(C)(C)C(O)=O)c1csc(N)n1)C([O-])=O
References
1. Hazumi N, Matsuda K, Sanada M, Ohtake N, Tanaka N. Resistance to a new catecholic cephem, BO-1341, in Pseudomonas aeruginosa PAO. J Antimicrob Chemother. 1992 Mar;29(3):287-97. PubMed PMID: 1592698.
2. Nakagawa S, Sanada M, Matsuda K, Hashizume T, Asahi Y, Ushijima R, Ohtake N, Tanaka N. In vitro and in vivo antibacterial activities of BO-1341, a new antipseudomonal cephalosporin. Antimicrob Agents Chemother. 1989 Sep;33(9):1423-7. PubMed PMID: 2510590; PubMed Central PMCID: PMC172677.
3. Sanada M, Hashizume T, Matsuda K, Nakagawa S, Tanaka N. Mode of action of BO-1341: transport pathway through the outer membrane of Escherichia coli. Drugs Exp Clin Res. 1988;14(6):397-402. PubMed PMID: 3063475.
4. Hashizume T, Sanada M, Nakagawa S, Tanaka N. Comparison of transport pathways of catechol-substituted cephalosporins, BO-1236 and BO-1341, through the outer membrane of Escherichia coli. J Antibiot (Tokyo). 1990 Dec;43(12):1617-20. PubMed PMID: 2276982.